Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Stopping afatinib improved a rare scalp condition in a patient.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Stem cell therapy could help regenerate inner ear hair cells to treat hearing loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.